Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412 [Expanded access from profile 700036424].

Trial Profile

Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412 [Expanded access from profile 700036424].

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 31 Jul 2015

At a glance

  • Drugs Ficlatuzumab (Primary)
  • Indications Ovarian cancer
  • Focus Expanded access; Therapeutic Use
  • Sponsors AVEO Oncology
  • Most Recent Events

    • 28 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 25 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top